menu
    • menu

    Company profile for Korro Bio

    NEW Drugs in Dev: 1
    Trusted Global CDMO Partner Delivering End-to-End Pharma Manufacturing & Development Solutions.

    Virtual Booth

    Contact Supplier

    Evonik Health Care is the innovation hub for leading life science companies

    Virtual Booth

    Contact Supplier

    Aarti Pharmalabs is a partner of choice for pharmaceutical companies for APIs & Intermediates. Largest Indian producer of Caffeine.

    Virtual Booth

    Contact Supplier

    Axplora is your partner of choice for complex APIs.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    KORRO BIO IS CREATING TRANSFORMATIVE THERAPEUTICS for patients by selectively editing messenger RNA to recode specific codons to deliver a beneficial change in protein sequence, structure and function.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Korro BioUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    KORRO BIO, INC. ‍400 Technology Square, ​10th Floor Cambridge, MA 02139
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.korrobio.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    BioProcess International US West

    Not Confirmed

    envelop Contact Supplier

    BioProcess International US West

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Korro To Present At TD Cowen Health Care Conference
    Korro To Present At TD Cowen Health Care Conference

    25 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/25/3244979/0/en/Korro-to-Present-at-the-TD-Cowen-46th-Annual-Health-Care-Conference.html

    GLOBENEWSWIRE
    25 Feb 2026
    Share Share
    Korro To Host Virtual Analyst Day On January 27, 2026
    Korro To Host Virtual Analyst Day On January 27, 2026

    20 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/20/3221643/0/en/Korro-to-Host-Virtual-Analyst-Day-on-January-27-2026.html

    GLOBENEWSWIRE
    20 Jan 2026
    Share Share
    JPM26: Korro Bio Looks To Save Itself Despite Unenviable Position
    JPM26: Korro Bio Looks To Save Itself Despite Unenviable Position

    16 Jan 2026

    // BIOSPACE

    https://www.biospace.com/business/jpm26-korro-bio-looks-to-save-itself-despite-unenviable-position

    BIOSPACE
    16 Jan 2026
    Share Share
    Korro To Present At J.P. Morgan Healthcare Conference
    Korro To Present At J.P. Morgan Healthcare Conference

    08 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/08/3215287/0/en/Korro-to-Present-at-the-44th-Annual-J-P-Morgan-Healthcare-Conference.html

    GLOBENEWSWIRE
    08 Jan 2026
    Share Share
    Korro Lays Off Staff As Lead Drug Disappoints, Novo Pauses Pact
    Korro Lays Off Staff As Lead Drug Disappoints, Novo Pauses Pact

    13 Nov 2025

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/korro-lays-34-staff-lead-drug-disappoints-and-novo-nordisk-pauses-pact

    FIERCE BIOTECH
    13 Nov 2025
    Share Share
    Korro Updates Q3 Financials, Progress On KRRO-110
    Korro Updates Q3 Financials, Progress On KRRO-110

    12 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/12/3186799/0/en/Korro-Reports-Third-Quarter-Financial-Results-Provides-Updates-on-KRRO-110-in-Alpha-1-Antitrypsin-Deficiency-and-Additional-Pipeline-Programs.html

    GLOBENEWSWIRE
    12 Nov 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search